間質幹細胞市場：依細胞來源、應用、最終用戶和地區分類

Mesenchymal Stem Cells Market, By Cell Source, By Application, By End-User, By Geography

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，間質幹細胞市場規模將達50.1億美元，2033年將達到106.7億美元。預計從2026年到2033年，其複合年成長率將達到11.4%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	50.1億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	11.40%	預計金額（2033 年）	106.7億美元

全球間質幹細胞市場涵蓋多種細胞來源，如骨髓來源間質幹細胞、脂肪來源間質幹細胞和臍帶來源間質幹細胞，並應用於再生醫學、免疫調節和組織工程等領域。這些產品被醫院、診所、科研機構、學術機構和受託研究機構（CRO）廣泛採用，從而提升了效率、性能和可靠性。這些領域應用範圍的不斷擴大，以及持續的產品創新，將繼續推動市場成長。

市場動態：

預計推動全球間間質幹細胞市場成長的主要因素包括：關鍵應用領域需求的成長、對效率和性能日益重視以及持續的產品創新。醫院、診所、研究機構和學術機構對間質幹細胞的廣泛應用，以及對先進解決方案投資的增加，也將進一步促進市場擴張。

例如，供應商正日益開發針對再生醫學及相關應用領域的客製化解決方案。此外，持續的研發投入和新技術的整合預計將在預測期內為市場參與者創造新的成長機會。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司概況、產品系列、主要亮點、財務績效和策略等參數，介紹了全球間質幹細胞市場主要參與者的概況。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
本市場報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用分析全球間質幹細胞市場中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 比荷盧經濟聯盟
- 丹麥
- 挪威
- 瑞典
- 其他歐洲國家
亞太地區
- 中國
- 台灣
- 印度
- 日本
- 印尼
- 馬來西亞
- 菲律賓
- 新加坡
- 澳洲
- 韓國
- 其他亞太國家
中東和非洲
- 巴林
- 科威特
- 阿曼
- 卡達
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 北非
- 中非
- 其他中東國家

第8章競爭情勢

Mesoblast Ltd.
Takeda Pharmaceutical Company
Lonza Group AG
Thermo Fisher Scientific Inc.
Pluristem Therapeutics Inc.
Novartis AG
Athersys Inc.
Cytori Therapeutics, Inc.
Medipost Co. Ltd.
Celyad Oncology

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI720

Mesenchymal Stem Cells Market is estimated to be valued at USD 5.01 billion in 2026 and is expected to reach USD 10.67 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 5.01 billion
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.40%	2033 Value Projection:	USD 10.67 billion

The global mesenchymal stem cells market comprises cell source categories such as Bone Marrow-derived MSC, Adipose-derived MSC, and Umbilical Cord-derived MSC, serving applications including Regenerative Medicine, Immunomodulation, and Tissue Engineering. These offerings are adopted across Hospitals & Clinics, Research & Academic Institutes, and Contract Research Organizations (CROs) and other areas, where they support improved efficiency, performance, and reliability. Growing adoption across these segments, combined with ongoing product innovation, continues to support expansion of the market.

Market Dynamics:

Rising demand across key application areas, increasing emphasis on efficiency and performance, and continued product innovation are major factors expected to drive growth of the global mesenchymal stem cells market. Expanding adoption among Hospitals & Clinics, and Research & Academic Institutes and growing investment in advanced solutions are further supporting market expansion.

For instance, providers are increasingly developing offerings tailored to Regenerative Medicine and related applications. Moreover, ongoing research and development, along with the integration of new technologies, is expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global mesenchymal stem cells market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Mesoblast Ltd., Takeda Pharmaceutical Company, Lonza Group AG, Thermo Fisher Scientific Inc., Pluristem Therapeutics Inc., Novartis AG, Athersys Inc., Cytori Therapeutics, Inc., Medipost Co. Ltd., and Celyad Oncology, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global mesenchymal stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mesenchymal stem cells market.

Detailed Segmentation:

Global Mesenchymal Stem Cells Market, By Cell Source (Revenue, USD Bn, 2021 - 2033)
Bone Marrow-derived MSC
Adipose-derived MSC
Umbilical Cord-derived MSC
Other Sources
Global Mesenchymal Stem Cells Market, By Application (Revenue, USD Bn, 2021 - 2033)
Regenerative Medicine
Immunomodulation
Tissue Engineering
Others
Global Mesenchymal Stem Cells Market, By End-User (Revenue, USD Bn, 2021 - 2033)
Hospitals & Clinics
Research & Academic Institutes
Contract Research Organizations (CROs)
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
Mesoblast Ltd.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
Takeda Pharmaceutical Company
Lonza Group AG
Thermo Fisher Scientific Inc.
Pluristem Therapeutics Inc.
Novartis AG
Athersys Inc.
Cytori Therapeutics, Inc.
Medipost Co. Ltd.
Celyad Oncology

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Cell Source
- Market Snapshot, By Application
- Market Snapshot, By End-User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
Partnership Scenario
Brand and Pricing Analysis
Distributors Landscape
Porters Analysis
Technological Advancements
Key Developments
Market Trend
Future Prospective
Top Market Players by Revenue

4. Mesenchymal Stem Cells Market, By Cell Source, 2026-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Bone Marrow-derived MSC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Adipose-derived MSC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Umbilical Cord-derived MSC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Other Sources
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

5. Mesenchymal Stem Cells Market, By Application, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Immunomodulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

6. Mesenchymal Stem Cells Market, By End-User, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Research & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

7. Mesenchymal Stem Cells Market, By Region, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Benelux
  - Denmark
  - Norway
  - Sweden
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - China
  - Taiwan
  - India
  - Japan
  - Indonesia
  - Malaysia
  - Philippines
  - Singapore
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - Bahrain
  - Kuwait
  - Oman
  - Qatar
  - Saudi Arabia
  - UAE
  - Israel
  - South Africa
  - North Africa
  - Central Africa
  - Rest of Middle East

8. Competitive Landscape

Mesoblast Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lonza Group AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pluristem Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Athersys Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cytori Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Medipost Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Celyad Oncology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies